Effect of valerian on anxiety

Phase 2

• Conditions: Axiety.; Anxiety disorder, unspecified

• Registration Number: IRCT2014042717454N1
• Lead Sponsor: Vice chancellor for research, Zanjan University of Medical Scinces

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Working in intensive care units at least for one month; endorsing informed consent form; not having any diagnostic physical and mental disease; not using any sedatives, hypnotics, barbitorates, benzodiazepines, narcotics or alcohol; getting score 20 from Speilberger´s anxiety inventory that means having anxiety; not using other relaxant methods like aromatherapy, yuga, acupuncture and so on; not being pregnant or breast feeding. Exclusion criteria: Getting score 20 and less than 20 that means not having anxiety according to Speilberger´s anxiety inventory; not using valerian or placebo during study or on the other hand not cooperating; pregnancy diagnosing; outbreaking severe side effects and participant´s no tendency to continue the trial.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety. Timepoint: Before intervention and one week after intervention. Method of measurement: Using the Spielberger State -Trate Anxiety inventory.

Secondary Outcome Measures

Name	Time	Method
Anxiety decrease. Timepoint: one week after begining of intervention. Method of measurement: Speilberger's anxiety inventory.